Recombinant Human Phosphoglycerate mutase 2 (PGAM2)

Uniprot Id

P15259

Target Species

Human

Target Name

PGAM2

Target Full Name

Phosphoglycerate mutase 2

Target Function

Interconversion of 3- and 2-phosphoglycerate with 2,3-bisphosphoglycerate as the primer of the reaction. Can also catalyze the reaction of EC 5.4.2.4 (synthase), but with a reduced activity.

Target Involvement

Glycogen storage disease 10 (GSD10)

Target Protein Families

Phosphoglycerate mutase family, BPG-dependent PGAM subfamily

Target Tissue Specificity

Expressed in the heart and muscle. Not found in the liver and brain.

Target Synonyms

BPG dependent PGAM 2; BPG-dependent PGAM 2; GSD10; MGC88743; Muscle specific phosphoglycerate mutase; Muscle-specific phosphoglycerate mutase; OTTHUMP00000207787; PGAM 2; PGAM M; PGAM-M; Pgam2; PGAM2_HUMAN; PGAMM; phosphoglycerate mutase 2 (muscle); Phosphoglycerate mutase 2; Phosphoglycerate mutase isozyme M

Target Background

Phosphoglycerate mutase (PGAM) catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway. The PGAM is a dimeric enzyme containing, in different tissues, different proportions of a slow-migrating muscle (MM) isozyme, a fast-migrating brain (BB) isozyme, and a hybrid form (MB). This gene encodes muscle-specific PGAM subunit. Mutations in this gene cause muscle phosphoglycerate mutase eficiency, also known as glycogen storage disease X.